Peter Laird, PhD, discusses his studies of epigenetics and the role DNA methylation may play in contributing to cancer. Dr. Laird highlights the importance of better tools and being able to choose the right one for your research — from Illumina microarrays for quick work and a lot of samples http://www.illumina.com/techniques/microarrays.html to next-generation sequencing for understanding more detail about the whole genome http://www.illumina.com/technology/next-generation-sequencing.html.
Researcher: Peter Laird, PhD
Professor at the Center for Epigentics
The Van Andel Research Institute
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.
*Data calculations on file. Illumina, Inc., 2015.
View related videos
Scott Weiss: Population Studies, Biobanks and Arrays
View related information
Subscribe to the Illumina video channel